Bicara Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $4.2M |
| FY2023 | $15.5M | $234.0M | $230.4M |
| FY2024 | $18.1M | $510.0M | $489.7M |
| FY2025 | $29.5M | $431.0M | $96.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $4.2M |
| FY2023 | $15.5M | $234.0M | $230.4M |
| FY2024 | $18.1M | $510.0M | $489.7M |
| FY2025 | $29.5M | $431.0M | $96.7M |